A review of obesity pharmacotherapy published on NCBI describes a 12-week AOD 9604 trial in which the treated group lost more body fat than placebo without altering glucose control
Supporting metabolism, protecting lean mass, and addressing deficiencies early helps prevent the fatigue and plateaus that sometimes occur later in treatment
Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes
They are common in adult patients, but uncommon in children
This targeted therapy combines Vitamin B12, Vitamin B6, and MIC (Methionine, Inositol, and Choline) a synergistic formula that works to enhance energy production, support liver detoxification, and promote healthy fat metabolism